Bausch Health Companies Inc.BHC

NYSEHealthcarePharmaceuticals$4.96-1.78%

A multinational specialty pharmaceutical company focused on developing, manufacturing, and marketing a range of branded and generic pharmaceuticals, medical devices, and over-the-counter products. Investors monitor Bausch Health for its turnaround efforts, patent cliffs, and exposure to gastroenterology and dermatology markets.

Market Cap: $1.8B52W Range: $4.25 – $8.69

Congressional Interest in Bausch Health Companies Inc. (BHC)

3 members of Congress have disclosed 11 trades in Bausch Health Companies Inc. (BHC), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.